肝移植显著延长酒精相关肝病患者的生存期,但存在性别和种族差异
Liver transplant linked to significantly extended survival for alcohol-associated disease yet access is not equitable
一项大型研究发现,肝移植显著延长酒精相关肝病患者的生存期,但女性和非洲裔美国人接受移植的比例较低。研究分析了2017年至2024年间超过37万名患者的保险索赔数据,显示移植患者平均生存时间比未移植患者长25%至45%,且调整后死亡风险降低63%。
研究显示肝移植显著延长酒精相关肝病患者的生存期,但存在性别和种族差异。
People with alcohol-associated liver disease who received a liver transplant survived years longer than those who did not, but there are disparities in which patients receive a transplant. A large study published in Alcohol: Clinical and Experimental Research found that liver transplantation was associated with significantly longer survival in both the short term and longer term. Yet, women and African Americans had lower odds of receiving a transplant, even though neither group had a higher risk of death than men or white patients.
The study supports the substantial benefit of liver transplantation for people with alcohol-associated liver disease and highlights a need for policies and practices that ensure equitable access to this life-lengthening treatment.
The study analyzed national insurance claims data of commercially insured and Medicare Advantage patients who were diagnosed with alcohol-associated liver disease from 2017 to 2024, including any preexisting health issues in the 10 years prior to diagnosis.
Unlike most earlier studies, which began follow-up at the time of transplant, this study followed patients from their first diagnosis, capturing the period before transplant when many patients become sicker or die while waiting. The study estimated average survival time within three, five and eight years after diagnosis. The study design and large national cohort provide a real-world view of liver transplantation outcomes.
Of the more than 370,000 patients in the study, about 3,500 received liver transplants. Those who received a liver transplant lived longer over every follow-up period, with 25% to 45% longer average survival time and a 63% lower adjusted risk of death. Over the first eight years after diagnosis, transplant recipients lived, on average, about 7.1 years compared to about 4.9 years for people who did not receive a transplant.
Because this was an observational study and transplant recipients tended to be younger and healthier in other respects, the authors adjusted for these differences; even so, the findings show an association rather than proof that transplantation alone caused the longer survival.
Differences in who did and did not receive liver transplants were evident by age, sex, race and coexisting health conditions. Even after adjusting for liver disease severity and comorbidities, disparities persisted, notably among women and African Americans, who had lower odds of receiving a liver transplant.
People with nonmetastatic liver cancer, people with symptoms of liver decompensation and people with alcohol-associated cirrhosis had increased odds of transplant, whereas people with a recorded diagnosis of alcohol use disorder had less than half the odds. These liver conditions were also associated with a higher risk of death, possibly reflecting delayed referral or advanced disease at the time of transplant evaluation.
The study demonstrates the substantial survival benefit associated with liver transplantation for people with alcohol-associated liver disease and underscores the need for improvements to ensure equitable systems for referral and treatment to eliminate disparities.
More information
Wanzhu Tu et al., Long‐Term Survival of Liver Transplantation in Alcohol‐Associated Liver Disease: Insights From National Claims Data, Alcohol: Clinical and Experimental Research (2026). DOI: 10.1111/acer.70416
Key medical concepts
Clinical categories
Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Liver transplant linked to significantly extended survival for alcohol-associated disease yet access is not equitable (2026, November 9) retrieved 9 November 2026 from https://medicalxpress.com/news/2026-11-liver-transplant-linked-significantly-survival.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com